Racial and Gender Discrimination When Tailoring Medical Management to Hypertension Treatment in Latin America

Area of Science:

• Cardiovascular medicine
• Public health
• Health equity

Background:

• Cardiovascular disease (CVD) is a leading global cause of death.
• Significant disparities persist in cardiovascular healthcare delivery in Latin America.
• Marginalized populations, including women, ethnic minorities, and low-income groups, face substantial barriers to care.

Purpose of the Study:

• To highlight the complex issue of discrimination in hypertension treatment in Latin America.
• To identify key drivers of these disparities: gender, ethnicity, and economic status.
• To advocate for strategies that ensure equitable access and quality of care for all populations.

Main Methods:

• Analysis of existing literature and data on cardiovascular healthcare disparities in Latin America.
• Review of socio-economic and ethnic factors influencing hypertension treatment.
• Endorsement of consensus recommendations addressing personalized care, racial bias, socioeconomic inequalities, and gender disparities.

Main Results:

• Women, ethnic minorities, and economically disadvantaged individuals experience underrepresentation in research, delayed diagnoses, and unequal access to recommended treatments.
• Economic status directly correlates with healthcare quality, exacerbating inequities for lower-income communities.
• Ethnic discrimination leads to inadequate care and limited access to advanced medical technologies for indigenous and Afro-descendant populations.

Conclusions:

• Comprehensive strategies are needed to dismantle biases, improve access for disadvantaged communities, and ensure equal quality of care for ethnic minorities.
• Equitable participation in clinical trials and culturally sensitive public health policies are essential.
• Removing discriminatory barriers is vital to reduce the burden of cardiovascular disease and enhance health outcomes across Latin America.